Keyphrases
Neuroinvasiveness
100%
Antiretroviral Therapy
100%
AIDS/HIV
100%
Neuropathogenesis
100%
Subtype C HIV-1
66%
HIV Infection
50%
Opportunistic Infections
39%
Neuropathology
36%
Viral
33%
New Infections
33%
HIV-1 Subtype C
33%
Infection Resistance
20%
HIV-1 Infection
20%
Infected Individual
20%
Disease Progression
20%
HIV Neuropathogenesis
20%
Sub-Saharan Africa
20%
Motor Function
16%
Possible Mechanisms
16%
Disease Manifestations
16%
Drug Resistance
16%
Fast-growing
16%
Mycobacterium Tuberculosis (M. tb)
16%
Lymphocyte Infiltration
16%
HIV Drugs
16%
Treatment Regimen
16%
Specific Intent
16%
Africa
16%
Neurological Manifestations
16%
Invasiveness
16%
Human Immunodeficiency Virus Type 1 (HIV-1)
16%
Infection Rate
16%
Prevention Programs
16%
Effect Mechanism
16%
Disease Pathogenesis
16%
Preventive Strategies
16%
Distinct Subtypes
16%
Central Nervous System
16%
Zambia
16%
HIV Disease Progression
16%
Sanctuary
16%
Disease Management
16%
HIV-associated
16%
Asia
16%
Persistent Infection
16%
Meningitis
16%
Poverty
16%
Viral Compartmentalization
16%
HIV Viral Load
16%
Behavioral Task
16%
Neuroinflammation
16%
Neurocognitive Impairment
16%
Opportunistic Diseases
6%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Antiretroviral Therapy
69%
Human Immunodeficiency Virus Type 1 Subtype C
69%
Human Immunodeficiency Virus Infection
41%
Opportunistic Infection
32%
Disease Exacerbation
30%
Neuropathology
30%
Infection
30%
Disease
16%
Human Immunodeficiency Virus 1 Infection
16%
Infection Resistance
16%
Disease Management
13%
Central Nervous System
13%
Persistent Infection
13%
Mycobacterium Tuberculosis
13%
Neuroinflammation
13%
Drug Resistance
13%
Lymphocytic Infiltration
13%
Neurologic Finding
13%
Antiviral Therapy
13%
Infection Rate
13%
Motor Performance
13%
Meningitis
13%
HIV/AIDS
13%
Immunology and Microbiology
Human Immunodeficiency Virus
100%
Human Immunodeficiency Virus Type 1 Subtype C
97%
Human Immunodeficiency Virus Infection
48%
Opportunistic Infection
38%
Human Immunodeficiency Virus 1
19%
Infection Resistance
19%
Infection Rate
16%
Aseptic Meningitis
16%
Drug Resistance
16%
Mycobacterium Tuberculosis
16%
Central Nervous System
16%
Scale up
16%
HIV/AIDS
16%
Motor Performance
16%
Viral Load
16%
Virotherapy
16%